These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15886563)

  • 21. TNF-inhibitor induced lupus in a patient treated with adalimumab for rheumatoid arthritis.
    Lieberman MR; Liebman TN; Alapati U; Khachemoune A
    Dermatol Online J; 2014 Dec; 21(2):. PubMed ID: 25756476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leflunomide-induced subacute cutaneous lupus erythematosus.
    Goëb V; Berthelot JM; Joly P; Mejjad O; de Quatrebarbes J; Reynaud-Hautin C; Vittecoq O; Le Loët X
    Rheumatology (Oxford); 2005 Jun; 44(6):823-4. PubMed ID: 15757964
    [No Abstract]   [Full Text] [Related]  

  • 23. Etanercept-induced subacute cutaneous lupus erythematosus.
    Bleumink GS; ter Borg EJ; Ramselaar CG; Stricker BH
    Rheumatology (Oxford); 2001 Nov; 40(11):1317-9. PubMed ID: 11709621
    [No Abstract]   [Full Text] [Related]  

  • 24. Infliximab induced lupus in patients with rheumatoid arthritis.
    Elkayam O; Caspi D
    Clin Exp Rheumatol; 2004; 22(4):502-3. PubMed ID: 15301255
    [No Abstract]   [Full Text] [Related]  

  • 25. Chilblain lupus induced by TNF-α antagonists: a case report and literature review.
    Sifuentes Giraldo WA; Ahijón Lana M; García Villanueva MJ; González García C; Vázquez Diaz M
    Clin Rheumatol; 2012 Mar; 31(3):563-8. PubMed ID: 22207249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients.
    Cavazzana I; Bobbio-Pallavicini F; Franceschini F; Bazzani C; Ceribelli A; Bravi E; Zingarelli S; Caporali R; Cattaneo R; Montecucco CM
    Clin Exp Rheumatol; 2007; 25(5):676-83. PubMed ID: 18078613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of remicade efficiency for the treatment of rheumatoid arthritis].
    Sultanova TZh
    Lik Sprava; 2010; (1-2):78-82. PubMed ID: 20608030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optic neuritis after infliximab therapy.
    Faillace C; de Almeida JR; de Carvalho JF
    Rheumatol Int; 2013 Apr; 33(4):1101-3. PubMed ID: 22198693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.
    De Bandt M; Sibilia J; Le Loët X; Prouzeau S; Fautrel B; Marcelli C; Boucquillard E; Siame JL; Mariette X;
    Arthritis Res Ther; 2005; 7(3):R545-51. PubMed ID: 15899041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lupus like syndrome induced by treatment with anti TNFalpha (infliximab): report of three cases].
    Benucci M; Nenci G; Cappelletti C; Manfredi M
    Recenti Prog Med; 2008; 99(7-8):363-6. PubMed ID: 18751615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-tumor necrosis factor therapy in patients with difficult-to-treat lupus nephritis: a prospective series of nine patients.
    Matsumura R; Umemiya K; Sugiyama T; Sueishi M; Umibe T; Ichikawa K; Yoshimura M;
    Clin Exp Rheumatol; 2009; 27(3):416-21. PubMed ID: 19604433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour necrosis factor alpha and use of infliximab. Safety during pregnancy.
    Shrim A; Koren G
    Can Fam Physician; 2005 May; 51(5):667-8. PubMed ID: 15934268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infliximab-related lupus and associated valvulitis: a case report and review of the literature.
    Chadha T; Hernandez JE
    Arthritis Rheum; 2006 Feb; 55(1):163-6. PubMed ID: 16463396
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY; Browning JC; Larsen F; Hsu S
    Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pustular skin lesions in patients treated with infliximab: report of two cases.
    Starmans-Kool MJ; Peeters HR; Houben HH
    Rheumatol Int; 2005 Sep; 25(7):550-2. PubMed ID: 15711788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infliximab-induced lupus or rheumatoid arthritis (RA) overlapping with systemic lupus erythematosus (SLE) unmasked by infliximab.
    Novak S; Cikes N
    Clin Exp Rheumatol; 2004; 22(2):268. PubMed ID: 15083903
    [No Abstract]   [Full Text] [Related]  

  • 38. Cutaneous lupus erythematosus and anti-TNF-alpha therapy: a case report with review of the literature.
    Levine D; Switlyk SA; Gottlieb A
    J Drugs Dermatol; 2010 Oct; 9(10):1283-7. PubMed ID: 20941956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Subacute cutaneous lupus erythematosus and cancer: two cases and literature review].
    Gantzer A; Regnier S; Cosnes A; Ortonne N; Wolkenstein P; Bagot M; Duong TA
    Ann Dermatol Venereol; 2011 May; 138(5):409-17. PubMed ID: 21570567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis.
    Vandevyvere K; Luyten FP; Verschueren P; Lories R; Segaert S; Westhovens R
    Clin Rheumatol; 2007 Dec; 26(12):2205-2206. PubMed ID: 17876646
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.